询 价
索取COA
产品描述
产品数据库
Introduction | |
Format | Genomic DNA |
Description | β-thalassemia (β-mediterraneananemia) refers to the A group of hemoglobinopathies in which synthesis is partially or completely inhibited. |
Technical Data | |
Mutation 1 | Variation site: -87(C>G) |
DNA Change: N/A | |
Zygosity: Heterozygous | |
Allelic Frequency: 50% | |
Chr position(GRCh37): Chr11.5248388C>G | |
Transcript: NM_000518.5 | |
Mutation 2 | Variation site: IVS-I-110(G>A) |
DNA Change: c.93-21G>A | |
Zygosity: Homozygous | |
Allelic Frequency: 100% | |
Chr position(GRCh37): Chr11.5248050C>T | |
Transcript: NM_000518.5 | |
Buffer | Tris-EDTA |
Product Information | |
Intended Use | Research Use Only |
Unit Size | 1ug |
Concentration | Download for COA |
Purofication | Download for COA |
DNA electrophoresis | Download for COA |
Sanger sequencing |
Figure 1. -87(C>G) Heterozygous Figure 2. IVS-I-110(G>A) Homozygous |
Storage | 2-8℃ |
Expiry | 36 months from the date of manufacture |